galantamine has been researched along with Inflammatory Bowel Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahgat, AK; El-Abhar, HS; Wadie, W; Wazea, SA | 1 |
1 other study(ies) available for galantamine and Inflammatory Bowel Diseases
Article | Year |
---|---|
Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-κB/HMGB1/RAGE and p-AKT/Bcl-2 pathways.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Galantamine; Inflammatory Bowel Diseases; Janus Kinases; Male; NF-kappa B; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Signal Transduction; STAT3 Transcription Factor | 2018 |